Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepadutant in Infants With Feeding Intolerance
NCT01532518Phase 2Completed
- Sponsor
- Menarini Group
- Start
- Aug 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of nepadutant in feeding intolerance, sponsored by Menarini Group. Started Aug 2011; status: completed.
02
Drugs
nepadutant
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on NCT01532518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01532518.